Form 8-K - Current report:
SEC Accession No. 0001193125-23-036052
Filing Date
2023-02-13
Accepted
2023-02-13 17:06:08
Documents
13
Period of Report
2023-02-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d410339d8k.htm   iXBRL 8-K 72667
5 GRAPHIC g410339g01g01.jpg GRAPHIC 108489
  Complete submission text file 0001193125-23-036052.txt   451870

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imra-20230213.xsd EX-101.SCH 2838
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20230213_lab.xml EX-101.LAB 19500
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20230213_pre.xml EX-101.PRE 12148
7 EXTRACTED XBRL INSTANCE DOCUMENT d410339d8k_htm.xml XML 3580
Mailing Address 1309 BEACON STREET SUITE 300 BROOKLINE MA 02446
Business Address 1309 BEACON STREET SUITE 300 BROOKLINE MA 02446 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39247 | Film No.: 23619730
SIC: 2834 Pharmaceutical Preparations